Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0AK8Q
|
|||
| Former ID |
DNC009767
|
|||
| Drug Name |
N-Hydroxy-E-3-(biphenyl-4-yl)-acrylamide
|
|||
| Synonyms |
CHEMBL556532; N-Hydroxy-E-3-(biphenyl-4-yl)-acrylamide; SCHEMBL3292226; SCHEMBL3290139
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
| Structure |
 |
Download2D MOL |
||
| Formula |
C15H13NO2
|
|||
| Canonical SMILES |
C1=CC=C(C=C1)C2=CC=C(C=C2)C=CC(=O)NO
|
|||
| InChI |
1S/C15H13NO2/c17-15(16-18)11-8-12-6-9-14(10-7-12)13-4-2-1-3-5-13/h1-11,18H,(H,16,17)/b11-8+
|
|||
| InChIKey |
YMXJQEHWXZULBO-DHZHZOJOSA-N
|
|||
| PubChem Compound ID | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Design, synthesis, and evaluation of biphenyl-4-yl-acrylohydroxamic acid derivatives as histone deacetylase (HDAC) inhibitors. Eur J Med Chem. 2009 May;44(5):1900-12. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.